Neuro Device

Neuro Device Group S.A. is among the fastest-growing technology companies in Central Europe! This is a huge honor, which – immodestly speaking – we worked hard for.

This edition of the Deloitte Technology Fast 50 Central Europe was record-breaking – out of over 450 submissions, more than 140 were from Poland, including ours.

We would like to thank the organizers for this recognition and the award in the Impact Stars category!

We are moving from Praga-Południe to the beautiful, green Żoliborz district. Our email address and phone numbers remain the same, but from now on you can find us at ul. Gen. Zajączka 28, 01-510 Warsaw.

Krzysztof Malej, Head of R&I took part in the NeuroTech Talk event. Krzysztof was talking about Voic – our comprehensive system for post-stroke aphasia therapy.

We have been nominated in the TUV NORD Polska Supermeni Jakości plebiscite in the SECURITY (BEZPIECZEŃSTWO) category. The voting continues until the end of September. Each person can vote once by providing their email address to which a link to the candidates’ list will be sent (from which you should pick us:). If the mission of Neuro Device Group S.A. is something you hold dear, that’s an opportunity to support us simply with a click!

Supermeni Jakości

On August 21 Paweł Soluch had the pleasure of speaking at International Conference Planet Masters with the Grow Your Company program.

Paweł talked about his leadership, how he managed to create a team and lead it a Freedom Focused Company. He also talked about the Voic project, which is on its best way to improve the reality of patients with neurologic problems.

Grow Your Company is a program that unites entrepreneurs from all over the world, who believe that an innovative company and team is the solution for great global challenges for humanity and that it will make the world a better place for all of us.

Pawel Soluch – Planet Masters – International Conference – https://planetmasters.net/pawel-soluch/

Environmental awareness is deeply rooted in the Neuro Device culture. That is why we’ve decided to celebrate the 40th birthday of our CEO by having 40 trees planted through Posadzimy.pl.

The trees will be planted this autumn in the Ogrodzieniec community, where a natural disaster caused a severe loss to the forest stand.

Our seedlings will create 44,40m2 of the forest, which will produce oxygen for 26,80 people annually, absorb 240 kg of carbon dioxide and 2320 kg of returned paper.

We are pleased to inform that at the end of May 2021, we had our electric brain stimulator nurostym tESm certified as a medical device, in accordance with the new European regulation on medical devices.

The certification includes tACS and tRNS current modes what makes nurostym tESm the first medical device of its kind in the world. We are proud that the highest quality of our solutions is being acknowledged repeatedly in clinical evaluations.

Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC.

With the end of March, we have concluded domestic tests of the LifeTone Baby Monitor. Several dozen children under 12 months participated in the study. We have managed to prove, that our breathing and life functions monitor works perfectly for children within this age group. Many thanks to all the parents of the children, who agreed to conduct tests in their homes operating the devices perfectly. But most of all, thank you for your openness and your will to support science. This home pilot program showed us that we’re moving in the right direction with our research and development of the baby monitor and that there is demand for this kind of device on the market. If you are eager to get more info on the project, visit the LifeTone bookmark on our website.

Our study aimed at people suffering from poststroke aphasia is underway. The volunteers for the study have many questions regarding the inclusion criteria, as well as the study itself. Neurostimulation still stirs a lot of emotions, so we have decided to give the public a closer look at the project. We invited three of its participants to talk about it in front of the camera. Hear the stories of Beata, Zygmunt, and Andrzej’s struggle with aphasia, and meet Barbara who supports her daughter in the difficult poststroke everyday life. Links to the videos below:

Zygmunt

Bogdan

Beata

Our patients communication system – CAMRI, is designed to work in the MRI environment. It was installed in a specialist neonatal incubator, bought with the money raised during the 27th final of The Great Orchestra of Christmas Charity (WOŚP). The photos were sent to us by doctor Przemysław Podgórski from the University Clinical Hospital of Jan Mikulicz-Radecki in Wroclaw. Thank you, doctor. The Great Orchestra of Christmas Charity has been helping sick children and seniors for almost 30 years. It is in moments like this that our job satisfaction reaches its zenith. When we can witness how the projects we create, make a real difference in patients’ health and lives, especially the youngest ones! You can read more about the CAMRI project here: https://neurodevice.pl/en/neuro_projekty/camri/

After a pandemic year, it basically seems obvious that 2021 should only get better. But that is too general a statement to agree with. Moreover, Covid-19 still wins against us, not us against it, so any scenario is possible. I also believe that this year will continue to be marked by great uncertainty.

Looking beyond neurostimulation, the following months will rather direct our attention to the further fight against the virus and its complications (also in the field of neurology and psychiatry). While life slowed down, we began to notice aspects unnoticed before – our closest home environment, for which we began to care more, but also a general outlook on the world and what we – humans mean in this world. Fortunately, we have started to care more about nature, which already gives us a very good start for our and our children’s future. My impression is that we are also more sensitive to fake news in the media, which should result in greater confidence in science in the future. In 2021 year we will work more effectively, at least for two reasons: because we will have to make up for what we could not do due to lockdowns; because we’ve learned that we don’t always have to meet in person (wasting time getting to the meeting, sometimes to the other side of the globe) to achieve our business goals.

The year 2021 in neurostimulation, and more broadly in neurology, should be a very interesting one.

First, the impact of the pandemic on remote therapy approaches. We keep hearing about a telemedicine boom. Institutions regulating the market of medical devices drew attention to the possibility of its wider application in diagnostics and therapy – Neuroelectrics has received approval for remote research on the tDC stimulator for drug-resistant epilepsy in children; Miro Health has implemented an online tool for diagnosing neurological disorders, i.e. the doctor can perform an effective diagnosis of the patient without inviting him to the office. The pandemic has significantly accelerated the acceptance of the so-called digital health and remote healthcare.

Second, the pandemic’s impact on mental health. Loneliness or post-Covid complications, such as depression, anxiety, strokes, attention and concentration disorders, and aphasia will accelerate work on the diagnosis and therapy of diseases within the mental health spectrum. Already we can see examples of startups building on the remote psychiatric consultation and online psychotherapy service. This trend will be strengthened and expanded with speech, memory, attention and concentration therapy, spatial-visual functions, thinking etc. I feel that the very issue of treating this type of disorders at home, i.e. a familiar and safe environment for the patient, will be a huge breakthrough in the effectiveness of therapy, not to mention the frequency of therapy sessions. Exercises performed at home will have a higher frequency.

Third, if the number of lockdowns decreases (which we can count on given the growing number of vaccinated people), I expect more clinical trials, including those of neuroscientific solutions. Over the past year, many companies and research groups have had to curtail their research. Our company has suffered a significant slowdown in our two clinical projects, and the third could not even start due to hospital closures. Now it will have to be made up for. The second issue is the effect of the pandemic, which has shown that many of the research projects can be done more effectively in patients’ homes. Regulatory institutions have sought to facilitate the transformation of clinical research into a decentralized approach. This trend will probably stay with us. The end result will be the faster emergence of new diagnostic and therapeutic solutions on the market. Hopefully, our Voic System will be among them.

Fourth, the development of neurostimulation has finally gained momentum. There are more and more publications on current and magnetic stimulation therapy. Within these areas, new forms are also emerging, e.g. in current stimulation – tACS, in magnetic – rTMS, and within it QPS, or ultrasound stimulation. At scientific conferences, it is more common to discus how to choose the parameters of stimulation to be effective, not whether such solutions work at all.

Fifth, the FDA’s Breakthrough Devices Program will speed up the market approval of devices (largely neuro-devices) that provide more effective treatment or diagnosis of life-threatening diseases. This gives hope for faster adaptation of solutions in the field of neuroprosthetics and neurostimulation.

Sixth, the latest Neuralink and Kernel presentations have highlighted how technologically and conceptually we are poised to improve lives and, in many cases, save the lives of patients who until recently had no or less hope. The media power of Elon Musk and Bryan Johnson is helping neuroscience enter the mainstream, thus accelerating the pace of works in the field of neuroprosthetics.

Seventh, the pandemic has shown how important it is the medical advancement, and this has entailed and will continue to stimulate increased investment in research and development as well as digital health. It will accelerate the entry of giants such as Alphabet, Amazon, Apple, Microsoft or Walmart, but also smaller technology companies to medicine and neuro. Especially e-commerce companies will increase their investments, because after a year of online shopping, they have more funds than ever before. Some forecasts show that only in 2021, investments in healthcare and medtech will double compared to 2020.

As for the eighth point, I could describe the influence of AI on neurodiagnostics and therapy, but this is a topic for a whole separate post…

Just as last year, Paweł Soluch was again one of the speakers at the Poland 2.0 Summit 2020. This year, due to the epidemiological situation, the event took place online and gained global character!

Paweł participated in the panel “Neuroprosthetics – human augmentation or restoration”, and brought closer the subject of neuroprosthetics to a curious audience.
We are glad that we could again contribute to this fantastic event!

After the final examinations were carried out at the neonatal ward at the hospital in Rzeszów, we have improved both our device and the dedicated app. We want to provide babies and their parents with the best product they could ask for to prevent SIDS.

Find more about the project here: https://www.neurodevice.pl/projekty-rd/lifetone-breathing-monitor/

We are starting recruitment for the next study, this time at home, to collect data on the life functions of children under one year of age and compare them with pulse oximeter data.

We would like to invite parents from Warsaw and neighbouring cities to take part in the study, during which we will ask you to record for 5 days your baby’s data in one of the following age groups: 0-3, 4-6, 7-9, 10-12 months old.

We want to check the functionality and intuitiveness of the new version of the app as well as form a reference database. We provide the participants with a remuneration of PLN 350 for 5 days of the study and constant contact with a specialist who will train them how to operate both the device and the pulse oximeter, as well as will answer all questions.

Send applications via our e-mail box: kontakt@neurodevice.pl

We are proud to announce that Mateusz Sipiora, Product Designer at Neuro Device, successfully defended his doctoral thesis, in which he presented and analysed the design of our aphasia rehabilitation device. The exact title of the doctoral dissertation is as follows:

“The influence of design, a field based in humanities, on the quality of research and comfort of people with neurological dysfunctions. Design project of a device supporting people affected by aphasia.”

Congratulations!

On 20-22 April, the online 2020 NYC Neuromodulation conference was held organised by Neuromodec, and Neuro Device simply could not refuse to participate. Of course, we took part in it remotely, sitting at our homes on sofas or in comfortable armchairs. We are very happy that in times of #covid19 such events are moving to the digital world and do not lose any value at all.

59 sessions from various fields – their common denominator: neuromodulation – were made available for free to everyone around the world. More than 250 experts connected to the participants using the Zoom platform to discuss their insights, specialisations and to offer their support.

We decided to implement much of what we heard in our solutions. And our R&U department sacrificed sleepless nights to acquire as much knowledge as possible. We hope that more events will move online, because in our opinion, every cancelled scientific conference is a loss for science.

A new project, co-created by Paweł Soluch and fellow specialists, has been launched!

The idea behind the Dose of Support is to help those who, during the coronavirus epidemic, give their best by treating and saving people, so that they are not left alone in this overwhelming situation:

„Praco“We enable healthcare professionals to contact therapists, psychologists, and coaches. We are also ready to provide healthcare services with material aid by linking them to companies and individuals who offer their help.”

For more information, please visit the project’s official website: https://dawkawsparcia.org

We are happy to announce that our device for monitoring vital functions in infants has completed its tests, which took place in the neonatology ward at the Pro-Familia Specialist Hospital in Rzeszów.

The connection between the device and a cardiac monitor was checked in the group of neonates and preterm babies qualified for the examination. We collected data from both devices and opinions from the staff, which will help us implement improvements.

Thank you very much for this fruitful cooperation.

Michał Księżopolski, Software Engineer, and Mateusz Orzechowski, Chief Technical Officer – Data Science Neuro Device department, joined the participants of the AI NEXTCon 2020 conference.

They spent four days in Seattle between 12 and 16 February and devoted themselves fully to broadening their knowledge on the use of AI in technology. The novel insight they came back with will certainly be used in more than one NDG project!

Justyna Żurawska, our Research and Innovation Analyst, took part in a course on transcranial magnetic and electrical stimulation organised by the German Neuroscience Society.

The event took place on 11-13 February and attracted tMS and tES specialists from all over Europe. Justyna confirms that the lectures were extremely interesting, and the knowledge gained there will certainly come in handy at the work for the whole R&I team.

The Neurological Therapy Centre Samodzielni is currently recruiting for a clinical trial for people affected by post-traumatic aphasia.

As part of the study, which takes place in Warsaw, language therapy using neurostimulation of the brain is conducted.
We encourage everyone who wishes to take part in the study and meets the required criteria to contact us.

You will find more information in the information leaflet attached below.

INFORMATION Flyer download Download

POSTER download Download

Paweł Soluch flew to Las Vegas to attend the annual meeting of the North American Neuromodulation Society and Emerging Technology Forum on 23-26 January.

For the 23rd time, neuromodulation specialists are meeting with colleagues from all over the world to exchange experiences and reflect together on the way forward for this future-oriented field of medicine.

Paweł Soluch is now officially a graduate of the Leadership Academy for Poland, organised by the Center for Leadership. Paweł had the opportunity to be among the graduates thanks to the FOCUS programme grant from the Foundation for Polish Science. We strongly recommend the development of quality leadership. We couldn’t be prouder of our CEO!

The Center for Leadership is an organisation promoting the development of leadership in Poland and connecting outstanding Poles who will shape the future of the country and the world by creating positive values, unlocking the hidden potential of people and organisations, inspiring them to actively participate in public affairs and undertake new initiatives that have a positive impact on the world. The Centre for Leadership offers scholarships as well as supports new standards in education and science in Poland, striving to establish a world-class university in Poland.

Photo: Foundation for Polish Science
Source: Center for Leadership

This year on St. Nicholas’ Day, we left our daily duties and sat down to make Christmas cards together. We will send our handmade greeting cards to our friends, partners, and suppliers. In our opinion, such cards have a much greater value than the ones we buy – literally and figuratively. Each card is priced at 10 zloty and as many cards as we manage to make, so much money will be allocated to a charity chosen personally by our CEO Paweł Soluch:

“I would like us to support the Mam Marzenie Foundation with our Christmas charity this year. Recently, I had the pleasure of meeting the people working at the Foundation. They are wonderful and very devoted to children, who have little time left to make their life dreams come true. It is one of the few foundations that increases its achievements every year, and all its employees are volunteers. It is worth helping such wonderful people!” 🎄

Paweł Soluch is visiting Chicago again this year. This time to take part in RSNA 2019: 105th Scientific Assembly and Annual Meeting organised by the Radiological Society of North America (RSNA), and to present our latest innovation Neuro Device Camri™ there.

Camri is an AI-compatible MRI system for communication between the patient and medical staff during MRI examinations. We believe that our device has the chance to revolutionise thinking about this examination that in the future will not be burdened with stress and discomfort in patients.

See the video presenting our device:
https://www.youtube.com/watch?v=cZRc9BC7H5Q&feature=youtu.be

On 14-16 November, Krzysztof Malej, Head of R&I, and Michał Księżopolski from Data Science had the pleasure to participate in a neuroprosthetics workshops.

Our experts went to Göttingen at the invitation of Blackrock Microsystems, whose representatives we had the pleasure to host in September this year. These were valuable and very effective three days!

Luiza Drygiel, Paulina Kufel and Paulina Ignatowska-Zaremba represented Neuro Device at the Women in Tech Summit 2019 event organised on 13-14 November in Warsaw. It was an opportunity to listen and meet inspiring women who have achieved success in various fields of science, IT, innovation and technology.

On 13 November, Paweł Soluch gave a lecture as part of the 2nd Research & Innovation Forum organised by Puls Biznesu.

The subject of the lecture was: FFC – Freedom Focused Company, or how behavioural aspects and team management can influence your work in the R&D area. Paweł discussed the impact of diversity on teamwork, leadership and teaming; how brain processes can influence teamwork and how to use this knowledge in management. Using Neuro Device as an example, he talked about how to build and maintain an organisational culture for pioneering technology companies.

On 29th October, Neuro Device had the pleasure to take part in FutureLab #TyTworzyszPrzyszłość (#YouCreateTheFuture) workshops, organised by PZU and MIT Enterprise Forum CEE.

Our team was represented by project manager Paulina Ignatowska-Zaremba and CEO Paweł Soluch. It was an excellent opportunity to discuss the future of technologies related to medicine and healthcare with representatives of start-ups and large companies.

We are glad that we were invited to join the group of such outstanding specialists and the organisers appreciated our efforts in the development of future medicine.

On 25-26 October in London, our CEO Paweł Soluch was one of the speakers at the Poland 2.0 Summit. In the panel devoted to innovation in medicine, Paweł raised such topics as the implementation of new technologies or clinical trials, and was accompanied by a representative of Trustedoctor. The debate was hosted by an Imperial College London moderator. Together they tried to answer the question: “Why is technological innovation a necessary step forward in medicine and healthcare?” We believe that their conversation was inspiring for the audience. Thank you once again for inviting us to such an important event.

Poland 2.0 Summit is an annual conference for professionals and students to present how innovation and technological progress change the future of life, business, and public policy, with particular emphasis on Poland’s role as a promising player in this field.

Paweł Soluch took part in the annual convention of the American Society of Neurorehabilitation – ASNR.

All specialists – doctors and neuroscientists – flew to the event held on 16-18 October in Chicago. At Neuro Device, we are constantly working on a system for the rehabilitation of posttraumatic aphasia. Neuromodulation is, in our opinion, the future of medicine, so we could not miss the most important event for neurorehabilitation professionals.

Krzysztof, Mateusz and Adam from our team had the pleasure to participate in the CME International Conference in Dortmund. The event was organised by the IfADo – Leibniz-Institut für Arbeitsforschung an der TU Dortmund. Our colleagues had the opportunity to meet biomedical engineering experts from all over the world and learn about the latest research on non-invasive brain stimulation.

The event was organised for the 13th time. We are happy to have been a part of it!

Neuro Device is one of the start-ups that were chosen by the President’s Chancellery to participate in the “Startups in the Palace – Cooperation” initiative.

On 9th September, Paweł Soluch together with Przemysław Kunert, PhD, from the Neurosurgery Clinic of the Medical University of Warsaw, and Marcus Gerhardt, President of Blackrock Microsystems, LLC were guests of the President’s Chancellery.

In a discussion with Marta Gajęcka, advisor to the President, they presented the effects of their work to date and plans of cooperation in the development of a neuroprosthetic system, which in the near future may significantly help patients with neurological trauma.

Thank you for your invitation!

Neuro Device became a mentor in the acceleration programme of the Polish Development Fund “BioMed Academy” addressed to innovative companies from the BioTech and MedTech sectors.

During the first day, Paweł, Luiza and Paulina talked about our company’s experience in overcoming challenges that young medical companies may face. Paweł talked about building a team in the spirit of Freedom Focused Company, an approach that supports the creation of innovation in technology organisations. Luiza presented how Neuro Device adapted SCRUM to hardware projects, while Paulina introduced the acceleration participants to Design Thinking and Service Design methodologies and talked about the latest trends in the biotechnology industry.

We are glad that we could share our knowledge with young innovators.

On 30th May, we organised a seminar entitled “New technologies in the diagnosis and therapy of children with autism spectrum disorders”. During the event, we presented the results of research conducted within the framework of the SENSEAS project, and the guests invited by us shared their experiences and thoughts on the application of technological solutions in the diagnosis and therapy of people with ASD.

The event was attended by almost a hundred people – therapists, teachers, parents, as well as representatives of ASD support centres. Speakers included: Michał Wroniszewski, President of the SYNAPSIS Foundation, Paweł Soluch, CEO of our company, dr Anna Guzik-Kornacka, SENSEAS project expert, Izabela Libold, co-founder of the Libold Rehabilitation Centre, and Radek Machnica, founder and President of the ALEKLAS Foundation.

For all those interested in the SENSEAS project and those who could not participate in the seminar, we have prepared a scientific atlas with the most important data and research results. It is available on the project website HERE.

The SENSEAS project, co-funded by the European Union, is the first system in the world to use multimedia techniques and psychophysiological measurements (eye-tracking, EDA/GSR) to help diagnose and treat ASD in young children.

Our partners in the project were SYNAPSIS Foundation and Media Bridge (zdjęcia)

We are pleased to announce that one of our projects – Neuro Device Voic – won the “Focus Lenses” voting organised by Focus monthly magazine and was awarded the title of the Best Polish Innovation of 2018. Internet users could vote for their favourites in four different categories for over a month. Our project won in the “health” category.

The winning solution Neuro Device Voic is a system for rehabilitation of people affected by aphasia, which works on the principle of neuromodulation. Its application will speed up the therapy and make it more accessible. Thanks to this, patients will be able to recover faster.

Focus magazine organised the competition for the 10th time. We would like to thank all the voters who helped us to win this jubilee edition. We congratulate our competitors and the winners of other categories.

W dniach 3 – 4 kwietnia wzięliśmy udział w spotkaniu matchmakingowym zorganizowanym dla firm wspieranych przez Europejską Radę ds. Innowacji (EIC). Spotkanie odbyło się w InQbet Accelerator w Brukseli. Byliśmy tam jedyną polską i jedną spośród ponad 100 firm, które miały okazję spotkać się z przedstawicielami dużych korporacji i ekspertów w dziedzinie otwartych innowacji.

Reprezentowała nas Paulina Ignatowska-Zaremba, nasza project manager, która podczas sesji pitchingowej zaprezentowała firmę i obecne projekty. Jesteśmy dumni ze świetnego występu Pauliny oraz z uczestnictwa w wydarzeniu, podczas którego mieliśmy okazję spotkać kreatywnych ludzi oraz nawiązać cenne relacje biznesowe.

On behalf of ourselves and our partners – the SYNAPSIS Foundation and Media Bridge – we invite you to participate in the closing seminar of the SENSEAS project. During the event, together with the invited experts, we will present the latest technological solutions currently used in the field.
We will try to answer the question of whether we are today able to help patients more effectively. We will also think about the future and how technologies will affect diagnostic methods and therapy for people with ASD in the coming years.

We invite everyone interested in the diagnosis and therapy of autism spectrum disorders – parents, therapists, teachers, educators, scientists, as well as representatives of centres supporting people with autism.
The event will take place on 30th May 2019 from 10:00 to 13:00 at the Foksal Press Centre at 3/5 Foksal Street in Warsaw.

Participation is free of charge, but prior registration is required – the registration form is HERE.

Please send any questions to: senseas@neurodevice.pl.

We are happy to announce that the report crowning the work on the project “Vocational activation of adults with autism spectrum using GSR technology” was published on the website of the SYNAPSIS Foundation – a partner with which we cooperated on this project.

During the study we checked the dermal and galvanic reactions of the subjects in order to answer the question whether GSR technology will enable the recording of signals preceding violent behaviour that may be unacceptable in the workplace. Such research combined with an individual approach to people with autism spectrum disorders can contribute to their more effective participation in the labour market.

The GRS bracelet – a device of our making – was the main tool for collecting EDA (Electrodermal Reaction) signals. You can read about how it turned out to be useful and what conclusions we reached together with specialists from the SYNAPSIS Foundation in the full report on the website: http://www.pracowniasynapsis.pl/images/GSR/Raport_Synapsis.pdf

One of our devices, the Neuro Device Scent™, was used in the study “Somatosensory response to tricuspid stimulation: a study of functional near infrared spectroscopy (fNIRS)” carried out by researchers from the Leibniz Research Centre for Working Environment and Human Factors in Dortmund and MSH Medical School Hamburg, University of Applied Sciences and Medical University.

The aim of the study was to show the neural response in the somatosensory cortex in reaction to irritating chemicals. This will allow the development of a relatively inexpensive, but innovative method for the objective assessment of volatile substances that irritate people.

Neuro Device Scent™ is our original olfactometer – a system for presenting olfactory stimuli during sensory analysis and examination of the nervous system, which allows to measure the reaction of the human neuronal system to odours.

The study is described in the Scientific Reports section of Nature Magazine, which you can read here: https://go.nature.com/2Bb2Xr3

We have joined an elite group of companies that will receive a grant from the European Innovation Council.

As part of the EU’s Horizon 2020 research and innovation programme, we will develop our project, Neuro Device Voic™. Support was granted under Phase I of the SME Facility. It will be used to develop the necessary analyses and, at the same time, to better prepare the project for applying for support under Phase II.

The European Innovation Council has selected 246 small and medium-sized enterprises from 24 countries for funding. Among them, there are 4 companies from Poland.

Neuro Device Voic™ is a project which aims to develop the world’s first system for effective rehabilitation of speech disorders (aphasia). According to the available data, such therapy is needed by as many as 1 in 250 people worldwide.

More about Neuro Device Voic™ project can be found here: https://www.neurodevice.pl/projekty-rd/neuro-device-voic/

Exactly 10 years ago, at the end of November 2008, Neuro Device was founded – the company created out of the need to help people has become one of the most important players on the international arena of research on the central nervous system.

10 years is a lot, especially in such a dynamic field as neuroscience. The speed at which we now discover the secrets of the brain is remarkable. In recent years, we have learnt more than in the previous 100 years, or since the beginning of neurological research. As there is still much to be discovered, we’ll gladly take part in the process. Since the very beginning, we have been working with the largest scientific institutions in the world to create advanced technological solutions to explore and treat what has so far been unexplored and incurable.

All this is the result of the work of many great people and institutions – employees, partners, contractors, and clients. Thank you for your trust, commitment and hard work. We hope that you will stay with us for the next years. There is still a lot to do – to investigate, discover, cure. We invite you to further cooperation and to create the history of neuroscience. So that in the next 10 years, we can look forward to another great success.

Together with the SYNAPSIS Foundation and MEDIA BRIDGE, we invite you to participate in the SENSEAS research project. The aim of the project is to create an objective system for diagnosing and treating young children affected by autism spectrum disorders. It is the first system in the world to use multimedia techniques and psychophysiological measurements (eye-tracking, EDA/GSR) at the same time, enabling the diagnosis of very young children, giving them a chance for a normal life in the future.

We invite children between 18 months and 4 years of age, who do not have any disability, and children with already diagnosed autism spectrum disorders, to participate in the study. The study, during which children watch cartoons, and a special apparatus follows the movements of their eyeballs, is completely non-invasive and passes away in a friendly atmosphere. Each participant in the study is another step to a better diagnosis and therapy of autism. We accept applications until 31st December 2018.

Contact for those interested in participating in the study:
Aneta Obłąkowska-Gwóźdź
phone: +48 505 301 114
e-mail: a.oblakowska@synapsis.org.pl

From 3 to 7 November, during the SfN 48th Annual Meeting 2018 in San Diego, we presented our innovative device for electrical transcranial stimulation: tES.

nurostym tES is a specialist solution for non-invasive stimulation of the central nervous system with a low-voltage current. It is designed for research and therapeutic purposes, e.g. in neurological rehabilitation after a stroke, in therapy of depression and addictions, and in relieving migraine headaches.

SfN 48th Annual Meeting 2018 is one of the most prestigious events in the scientific community dealing with the development of brain and nervous system science. It is organised by the Society for Neuroscience – an association that brings together 36,000 scientists from over 95 countries.

On 18th October, Paweł Soluch, CEO Neuro Device, gave a speech in Warsaw at the Inside Trends conference organised by Business Insider Polska. The event featured key figures from the fintech, life sciences, and digital business industries, who discussed global trends in the world of finance, medicine and health and new technologies.

Paweł appeared on the Life Science stage, where during the opening panel entitled “Is technology able to replace a human”, he discussed the future of technology in the context of human capabilities and limitations. The discussion was also attended by, among others, Mrs Monika Michalak, who had a stroke and is recovering much faster thanks to technological solutions.

“Technology is not yet able to replace the brain. Studying it is like eavesdropping on the conversation of two people in a stadium full of people,” said Paweł. He also stressed the importance of research on brain plasticity and brain stimulation, thanks to which it is easier to diagnose diseases and even save human lives.

The team representing the LifeTone project: Ewa Rutczyńska-Jamróz, Luiza Drygiel, and our CEO Paweł Soluch took part in the HUBWeek Innovation Festival held in early October in Boston. It is a prestigious event promoting ideas that change the world, to which we were invited as winners of this year’s edition of MITEF Poland (The MIT Enterprise Forum Start-up Acceleration Programme and Competition).

Our device was presented, among others, during the Showcase Demo Day, where the most promising projects, companies, and laboratories from around the world were shown. Participation in the event was also an opportunity to meet inspiring people and take part in a number of workshops.

LifeTone Baby Monitor is a small mobile device which, attached to a nappy, monitors the life functions of babies and very young children. It helps prevent many risks, such as cot death syndrome (SIDS). The project is currently in the prototype phase.

Neuro Device was invited to participate in the Polish Economic Exhibition, a prestigious multimedia exhibition organised by the Chancellery of the President of the Republic of Poland as part of the celebration of the 100th anniversary of Poland’s independence.

The exhibition showcases companies whose activities and achievements contribute to the development of dynamic and innovative economy of our country, such as Neuro Device. Visitors to the exhibition will be able to learn about our projects and achievements which support research and rehabilitation of people affected by neurological disorders.

The exhibition can be visited until 28th October in the Pavilion on Piłsudski Square in Warsaw.

More about the exhibition can be found here: https://pwg.prezydent.pl/katalog-firm/neuro-device/

Paweł Soluch, Neuro Device CEO, became one of the ambassadors of this year’s Chivas Venture competition for socially responsible projects. All thanks to the fact that in the previous edition we won the first place in Poland, and found ourselves in the top three of the international online vote.

Together with the ambassadors – winners of the previous editions of the competition, Paweł will participate in the proceedings of the Polish jury, support the participants and, hopefully, the world finalists representing our country.

Chivas Venture is an international competition for socially responsible companies, organised by the Chivas Regal brand. The winning projects receive financial support for further development and making the world a better place.

More about the competition can be found on the website: https://www.chivas.com/pl-pl/the-venture.

One of our projects, LifeTone, was among the winners of this year’s edition of MITEF Poland (The MIT Enterprise Forum Start-up Acceleration Programme and Competition), a programme for start-up companies supporting commercialisation of innovative projects.

In recent weeks, our LifeTone team participated in many meetings, workshops, and lectures organised as part of the programme, and now, thanks to the win, it will go to a bootcamp in Boston in October. There, together with international experts, they will work out the next steps on the path to a launch on international markets.

LifeTone is a small, wireless device for monitoring life parameters in infants and young children, which allows to avoid many risks, including cot death. More information about the device can be found here: https://www.neurodevice.pl/projekty-rd/lifetone-breathing-monitor/

On 20th June, we had the opportunity to represent Neuro Device during Polish Tech Day in London, where we also took part in Pitch To London – an annual competition presenting the winners of the most prestigious start-up competitions in Poland (as a reminder – we won the Polish edition of the Chivas Venture 2018 competition, we also took third place in the global online voting in this competition).

Although our competition was very strong and our project – a device supporting effective rehabilitation of aphasia, Neuro Device Voic™ did not ultimately win, it met with great interest from the participants of the event.

An event combining the two projects will take place in Warsaw from 15 to 17 June: The 6th Polish Eye-tracking Conference and the 2nd EARLI SIG 27 Conference. It will bring together ophthalmology specialists from all over the world, and will be an opportunity to broaden their knowledge about technology, share their own experiences and make new contacts. Three days filled with lectures and workshops will also give participants an opportunity to learn about the latest eye-tracking technology solutions.

Representatives of our company will also share their knowledge and experience. The event is organised by us in cooperation with The John Paul II Catholic University of Lublin, the University of Warsaw, and EARLI, an association of specialists in teaching research.

The partners of the event include: Tobii Pro, BIOPAC and Rogue Resolutions.

We are pleased to announce that our latest project – the world’s first system supporting the effective rehabilitation of aphasia – has been awarded the MedTec Startup Academy Award 2018.

The awarded device works on the principle of neuromodulation and non-invasive electrical brain stimulation. This will enable both acceleration of the rehabilitation and significant improvement of its effects, enabling patients to return to normal life.

Medtec Europe Start-Up Academy is an annual competition during which young European companies from the medtech industry present their latest projects and establish business contacts.

One of our products, LifeTone, has been qualified for the 4th edition of the acceleration programme MIT Enterprise Forum Poland. Therefore, for the next 3 months, representatives of our company will take part in workshops and sessions conducted by an international group of mentors and experts – representatives of the business world, who will support us in the development of our project, also on the international market.

LifeTone is an innovative method of measuring the life parameters of a child during sleep. It is a small mobile device which can be attached to a nappy and which is synchronised with an app on parents’ smartphones. This enables ongoing measurements of any parameters that could potentially affect sudden cot death (breath, temperature, position).

On 8th May, we took part in the meeting “Startups in the Palace – COOPERATION” organised by the Chancellery of the President of the Republic of Poland and the Startup Poland Foundation. The event was organised to support innovative Polish companies looking for development opportunities, investors, business partners and new markets.

During the event, we had the opportunity to get acquainted with the activities of the largest Polish companies, meet representatives of innovative business ventures and, most importantly, present our company and current projects.

We are happy to announce that we could stand on the podium of the first stage of the international Chivas Venture competition. Thanks to the votes of Internet users from all over the world, we were at the forefront of socially responsible startups, and thanks to the prize (20 thousand dollars), our project, a system for effective support of aphasia therapy, has a chance for faster implementation.

Aphasia is a speech disorder that prevents the affected person from communicating normally with others, communicating their needs, opinions, and emotions. Such patients cannot write, read or speak. According to the available data, this disorder affects 1 in 250 people in the world. Unfortunately, aphasia therapy is very difficult, long-lasting and unavailable for the majority of people. Our project, thanks to the involvement of Internet users, can change this.

More votes were only cast for startups from China and Brazil – LianDi and Revoada, which took first and second place respectively. Congratulations and we are glad that we found ourselves in such great company.

We thank all those who supported us, believed in our project, gave their votes and encouraged others to do so.

But it is not over yet. In less than a month’s time, we are going to Amsterdam for the very final of the Chivas Venture competition, in which there is a prize of USD 750 000 to be won. Here the jury will decide on the victory. If they choose our project, we will get funds for its further development, so that those suffering from aphasia all over the world will get a device that will help them get back to normal life quickly.

Keep your fingers crossed!

On the occasion of the Flag of the Republic of Poland Day, which we celebrate on 2nd May, we were invited to the Presidential Palace, where President Andrzej Duda gave us the Flag of the Republic of Poland. Thus, we found ourselves among the organisations honoured for many years of activity for the benefit of our neighbours and compatriots.

– “I hope that these white-and-red flags, which you will take with you and show your co-workers and colleagues, will be an incentive to work even better to the benefit of the Republic of Poland, for the fame of Poland at home and abroad”

said the President to those gathered in the courtyard of the Presidential Palace. This is a great honour for us, which coincided with the results of the online vote in the Chivas Venture competition. We are glad that our work is appreciated both at home and abroad.

Brainathon is an unusual event, a form of hackathon, which aims to develop brain-computer interface (BCI) technology that can be widely used in the treatment of severe neurological disorders such as Alzheimer’s disease, epilepsy or aphasia.

Participants of the event will have 24 hours to develop one of the selected projects based on brain-wave control (including a lamp, a computer game, an orthosis). The work on the projects will be supported by experienced scientists and engineers who have been developing BCI technology for years.

Brainathon will be held on 21-22 April this year at FutureLab – Intelligent Laboratory Space of the Future, which is part of the Poznan Supercomputing and Networking Center (PSNC). We invite anyone who knows a little bit about programming (JAVA and C is a minimum), is of age, speaks English, has a great deal of imagination, is willing to learn and improve the world. Participation in the event is free of charge. Applications are accepted until 10th April via the website: http://www.br41n.io/Poznan-2018. The best projects will be awarded with a cash prize of PLN 150,000 and new professional opportunities will be opened for their creators. Details concerning the event can be found here.

You can watch an animation promoting Brainathon here: https://www.youtube.com/watch?v=S5oOmVTWYrM

We won in the Polish edition of the competition for socially responsible projects – Chivas Venture. Every year, the creators of the competition invest USD 1 million in projects that change the world for the better and permanently affect the quality of human life. The jury selected the winner from about one hundred submitted projects, and the competition was run in 3 stages.

The idea of the winning project is to introduce the world’s first system for effective rehabilitation of speech disorders (aphasia). According to the available data, such therapy is needed by as many as 1 in 250 people in the world. The device can be used not only in professional therapy, but it will also enable home therapy. It will guarantee both acceleration of rehabilitation and significant improvement of its effects, enabling patients to return to normal life.

The final gala, during which the winner was selected, was attended by 400 people and the special guest was the Global Ambassador of the brand, actor Javier Bardem. We also want to congratulate the other great projects that made it to the final round: Biolumo, andervision, Hospicare and Food Outlet.

And now we have the world final ahead of us, which will take place at the end of May in Amsterdam.

The tES Stimulator designed by Neuro Device has been certified as a medical device. The certificate was issued by international certification body TÜV Nord.

This document confirms that the technical solutions used comply with the highest requirements of the EU directive on the safety of medical devices. The software of the stimulator limits the flow of current values that are safe for one’s health. In order to confirm safety, tests were also performed in a special laboratory.

We always approach our projects responsibly, remembering that we design every device with living people in mind. That is why the issue of equipment safety is so important to us.

Passion is one of the most valuable resources at Neuro Device. We have a wonderful team that is passionate not only about work but also after-work projects.

On Sunday 24th September 2017, four representatives of Neuro Device took part in the High five race (Bieg po piątkę) as part of 39th PZU Warsaw Marathon. Full of energy and joy, they ran a distance of five kilometres along the streets of our capital. It wasn’t easy, but the effort is what makes success taste so sweet.

We congratulate our marathon runners and wish them even better fitness. A healthy body is a home to a healthy spirit that is so needed in developing new, innovative ideas!

Neuro Device invites you to a workshop on transcranial brain stimulation.

From 13th to 14th October at the Military University of Technology, there will be a free workshop on transcranial brain stimulation. The event will be delivered by Professor Michael Banissy from Goldsmiths, University of London, who will talk about brain stimulation. Moreover, two latest devices will be presented: tES (nurostym) and TMS (DuoMAG). The lecture is open for everyone. On the second day, there will be a workshop on brain stimulation (registration required).

On 21-23 September 2017, Łódź will host the Physical Medicine and Rehabilitation Congress and Fair.

This is the 25th edition of the Congress. The event is the largest review of products and solutions for medical rehabilitation, physiotherapy, orthopaedics and health prevention in Poland. The programme includes 9 scientific sessions, 168 hours of lectures and workshops, 86 lecturers from Poland and abroad and 60 hours of workshops.

During the event, Neuro Device will conduct a workshop on the innovative method of posttraumatic rehabilitation using the brain-computer interface (BCI) – recoveriX.

We have concluded a cooperation agreement with the University of Gdańsk, one of the largest scientific institutions in Poland.

From now on, Neuro Device and the University will support each other in their activities, mainly through joint research and development, exchange of experience and expertise. As part of the joint activities, a study on new methods of mental training for athletes will be carried out, the aim of which is to create a tool for training the imagination of people working in sports.

An additional goal is to observe and examine whether neuroplastic changes after such training will affect the fitness of athletes. The initiatives undertaken together will contribute not only to the development of science, but also to the improvement of the quality of services of both parties.

We became a member of the i3B cluster. The name refers to technologies developed for the Brain, Body and Behaviour. It is an independent network established by the Dutch organisation ‘National Initiative Brain and Cognition (NIHC).

i3B is a group of high-tech companies and scientific institutions that are engaged in R&D or business activities in fields related to brain function, perception and cognition, physiology and behavioural issues.

Members represent companies, scientific institutions, and end users.